Cite
Low nuclear expression of HIF‐hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence‐free survival in clear cell renal cell carcinoma.
MLA
Luomala, Lassi, et al. “Low Nuclear Expression of HIF‐hydroxylases PHD2/EGLN1 and PHD3/EGLN3 Are Associated with Poor Recurrence‐free Survival in Clear Cell Renal Cell Carcinoma.” Cancer Medicine, vol. 13, no. 3, Feb. 2024, pp. 1–15. EBSCOhost, https://doi.org/10.1002/cam4.6998.
APA
Luomala, L., Mattila, K., Vainio, P., Nisén, H., Pellinen, T., Lohi, J., Laajala, T. D., Järvinen, P., Koskenniemi, A., Jaakkola, P., & Mirtti, T. (2024). Low nuclear expression of HIF‐hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence‐free survival in clear cell renal cell carcinoma. Cancer Medicine, 13(3), 1–15. https://doi.org/10.1002/cam4.6998
Chicago
Luomala, Lassi, Kalle Mattila, Paula Vainio, Harry Nisén, Teijo Pellinen, Jouni Lohi, Teemu D. Laajala, et al. 2024. “Low Nuclear Expression of HIF‐hydroxylases PHD2/EGLN1 and PHD3/EGLN3 Are Associated with Poor Recurrence‐free Survival in Clear Cell Renal Cell Carcinoma.” Cancer Medicine 13 (3): 1–15. doi:10.1002/cam4.6998.